Gilead Sciences, Inc. (GILD) Stock: A Year of Stock Market Dynamics

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Gilead Sciences, Inc.’s current trading price is -16.16% away from its 52-week high, while its distance from the 52-week low is 1.10%. The stock’s price range for this time frame has been between $72.87 and $87.86. The trading volume of the company’s shares in the Healthcare reached around 7.05 for the day, which was evidently higher than the average daily volume of 1.52 over the last three months.

The stock market performance of Gilead Sciences, Inc. has been fairly unsteady. Over the last year, the company’s stock hit its highest at $87.86 on 01/19/24, while the lowest price during the same time frame was $72.87, recorded on 02/09/24.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.

How Financial Performance Impacts Market Capitalization

Gilead Sciences, Inc. (GILD) has experienced a quarterly decline of -5.43% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 91.80B and boasts a workforce of Mar 14 2024 employees.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 78.52, with a change in price of -1.95. Similarly, Gilead Sciences, Inc. recorded 6,508,638 in trading volume during the last 100 days, posting a change of -2.58%.

How GILD’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for GILD stands at 1.10. Similarly, the long-term debt-to-equity ratio is also 1.02.

GILD Stock Stochastic Average

Gilead Sciences, Inc.’s raw stochastic average for the past 50 days is currently at 5.71%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 5.71%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 4.78% and 6.80%, respectively.

GILD Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Until today this year the stock’s price performance recorded a decrease of -9.06%. However, over the last six months, the performance has been stronger by -7.91%. The price of GILD decreased -12.82% over the last 30 days. And in the last five days, it has fallen by -4.27%.

Leave a Reply

Your email address will not be published. Required fields are marked *

On Key

Related Posts